Frontlight ResearchEarly access
Trial site
Fujian Cancer Hospital
- 9running trials
- 2closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Triple-negative breast cancer3 trials
- Cervical cancer2 trials
- Lung cancer2 trials
- Metastatic breast cancer2 trials
- Ovarian cancer2 trials
- Brain metastases1 trial
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Liver and biliary tract cancer1 trial
- Mesothelioma1 trial
- Prostate cancer1 trial
- Phase
- Phase 25 trials
- Phase 33 trials
- Phase 1/22 trials
- Phase 11 trial
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Completed2 trials
- Not yet recruiting2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Adcentrx Therapeutics1 trial
- BeiGene1 trial
- Beijing InnoCare Pharma Tech Co., Ltd.1 trial
- CSPC Megalith Biopharmaceutical Co.,Ltd.1 trial
- Daiichi Sankyo1 trial
- and 6 more
Running trials
Not yet recruiting
A Phase Ib/II Study of SYS6090 Combination Therapy in Advanced Colorectal Cancer
Recruiting
SHR-1701 in Combination With Stereotactic Body Radiotherapy in mCRPC
Enrolling by invitation
A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ovarian cancer2 recruiting
- Triple-negative breast cancer2 recruiting
- Cervical cancer1 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
- Mesothelioma1 recruiting
- Metastatic breast cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026